Crossmark

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials

Published Online: 2025-10-14

Authors

Li, Rongxia

Zhang, Xinmiao

Shen, Jinhai
License Information

Text and Data Mining valid from 2025-10-14

Version of Record valid from 2025-10-14
More Information

Article History

Received: 8 April 2025

Accepted: 12 September 2025

First Online: 14 October 2025

Declarations

:

: Not applicable.

: Not Applicable.

: The authors declare no competing interests.

Document is current